Fig. 2From: Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitusKaplan–Meier curves of freedom from all-cause mortality (a, b) and composite endpoints (c, d) for low and high HbA1c variability after 42-month follow-up in total HF patients. The numbers at the bottom of the figure are “number at risk”Back to article page